Skip to content

Released Feb 26, 2026, before the open

10-K filed Feb 26, 2026, 57 days after period end · 0001704292-26-000015

Q4 2025 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$130.06Mderived+18.4% vs Q4 2024+12.7% vs Q3 2025
Net Income-$50.41MderivedN/M vs Q4 2024N/M vs Q3 2025
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$69,406,000N/M
Operating Cash Flowderived-$26,022,000N/M
Free Cash Flowderived-$26,699,000N/M
Margins · derived
Operating margin-53.4%+8.4 pt vs Q4 2024
Net margin-38.8%+35.6 pt vs Q4 2024

What the release said

The release

Same quarter

MetricQ4 2025derived from reported figuresQ4 2024derived from reported figuresQ4 2023derived from reported figuresQ4 2022derived from reported figures
Revenue$130.06M$109.89M$65.83M$62.04M
Net Income-$50.41M-$81.68M-$95.43M-$61.77M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Zai Lab Ltd · CIK 1704292 · Engraved from SEC EDGAR